3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Head and Neck Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
32
Nasopharyngeal Carcinoma
22
Mouth Neoplasms
10
Oropharyngeal Neoplasms
8
Carcinoma, Squamous Cell
8
Laryngeal Neoplasms
7
Neoplasms
6
Melanoma
5
Lung Neoplasms
5
Colorectal Neoplasms
5
Pharyngeal Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Recurrence
2
Paranasal Sinus Neoplasms
2
Nasopharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Interventions
Cisplatin
19
Docetaxel
17
Cetuximab
12
Carboplatin
12
Radiotherapy
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
pembrolizumab
9
Paclitaxel
9
Radiotherapy, Intensity-Modulated
8
Immunohistochemistry
8
Erlotinib Hydrochloride
8
Trastuzumab
7
Gemcitabine
7
Chemotherapy, Adjuvant
7
Specimen Handling
6
Radiotherapy, Conformal
5
Radiosurgery
5
Gene Expression Profiling
5
Fluorodeoxyglucose F18
5
Capecitabine
5
Vorinostat
4
Taxes
4
Sorafenib
4
Polymerase Chain Reaction
4
Nivolumab
4
Bevacizumab
4
trastuzumab deruxtecan
3
sargramostim
3
bicalutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Drug Therapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled